By Sabela Ojea

Koninklijke Philips NV said Wednesday that it has received clearance for its removal laser sheath, named CavaClear, from the U.S. Food and Drug Administration.

The Dutch health-technology group said CavaClear is the first and only FDA-cleared solution for advanced inferior vena cava filter removal.

IVC filters are used to treat venous thromboembolism, in which blood clots form in the deep veins of the leg and groin, and can travel through the circulatory system, the company said.

Write to Sabela Ojea at sabela.ojea@wsj.com; @sabelaojeaguix

(END) Dow Jones Newswires

December 22, 2021 09:51 ET (14:51 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.
Grafico Azioni Koninklijke Philips NV (EU:PHIA)
Storico
Da Mar 2024 a Apr 2024 Clicca qui per i Grafici di Koninklijke Philips NV
Grafico Azioni Koninklijke Philips NV (EU:PHIA)
Storico
Da Apr 2023 a Apr 2024 Clicca qui per i Grafici di Koninklijke Philips NV